Latest News and Press Releases
Want to stay updated on the latest news?
-
PHILADELPHIA, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Inc. (NASDAQ: CYTK): Grabar Law Office is investigating claims on behalf of shareholders of Cytokinetics, Inc. (NASDAQ: CYTK). The...
-
PHILADELPHIA, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Inc. (NASDAQ: CYTK): Grabar Law Office is investigating claims on behalf of shareholders of Cytokinetics, Inc. (NASDAQ: CYTK). The...
-
PHILADELPHIA, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Inc. (NASDAQ: CYTK): Grabar Law Office is investigating claims on behalf of shareholders of Cytokinetics, Inc. (NASDAQ: CYTK). The...
-
PHILADELPHIA, Nov. 26, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Inc. (NASDAQ: CYTK): Grabar Law Office is investigating claims on behalf of shareholders of Cytokinetics, Inc. (NASDAQ: CYTK). The...
-
PHILADELPHIA, Nov. 25, 2025 (GLOBE NEWSWIRE) -- enCore Energy Corp. (NASDAQ: EU): Grabar Law Office is investigating claims on behalf of shareholders of enCore Energy Corp. (NASDAQ: EU). The...
-
PHILADELPHIA, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Fortrea Holdings, Inc. (NASDAQ: FTRE): Grabar Law Office is investigating claims on behalf of shareholders of Fortrea Holdings, Inc. (NASDAQ:...
-
PHILADELPHIA, Nov. 21, 2025 (GLOBE NEWSWIRE) -- Fortrea Holdings, Inc. (NASDAQ: FTRE): Grabar Law Office is investigating claims on behalf of shareholders of Fortrea Holdings, Inc. (NASDAQ:...